โ† All deals

PTC THERAPEUTICS, INC.

Public Equity (NASDAQ)BiotechnologyRare DiseasesPublic
๐Ÿ“ Warren, NJ, USโ€ข Founded 1998
StreetZero Signal 55
Be the first to signal interest

About PTC THERAPEUTICS, INC.

PTC Therapeutics, Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. The company advances a robust and diversified pipeline of transformative medicines to address unmet medical needs and leverages its scientific expertise and global commercial infrastructure. It is publicly traded on NASDAQ under the ticker PTCT and reported Q3 sales of $217.13 million. Headquarters are located in Warren, NJ.

LATEST FUNDINGRule 144
$178K
Announced 2026-11-16
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for PTC THERAPEUTICS, INC..

Free plan includes 3 full deal profiles every month.

Investors

Key highlights

  • Completed Rule 144 placement of $177,887.12 with undisclosed investors.
  • Entered $1B strategic financing collaboration with Blackstone Life Sciences and Blackstone Credit.
  • Publicly traded on NASDAQ (PTCT) since 2013 IPO.
  • Focuses on rare disorder treatments with reported Q3 revenue of $217.13 million.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account